Buc-ee's founder Arch Aplin III is gifting $50M to A&M's new facility. Buc-ee's/Facebook

The founder of Lone Star State’s favorite rest stop/gas station/car wash/cultural beacon has just made a Texas-sized investment in a major state university.

Buc-ee’s mastermind Arch “Beaver” Aplin III will commit $50 million toward establishing a Texas A&M University academic center that will serve as an immersive learning laboratory, the school announced.

Dubbed the Aplin Center (Aplin graduated from A&M in 1980), the hub will offer new university programs in hospitality, retail studies, and food product development through degree programs including viticulture, fermentation processes, coffee, and food science.

This new facility also will house product development laboratories and food tasting centers that can be utilized in partnership with related industries, according to a press release. Retail and food services areas will be managed by students and faculty. Students can also expect indoor and outdoor recreational spaces.

The center will be built across the street from the Texas A&M Hotel and Conference Center near Wellborn Road and Kyle Field.

Aplin’s $50 million commitment marks one of the largest single donations in Texas A&M history. “Arch ‘Beaver’ Aplin is a true visionary and one of the most creative entrepreneurs I have known,” said school president Dr. M. Katherine Banks in a statement. “He remains connected to his university, speaking to many students who share his passion for business and product development. Through this generous gift, he is creating a living, learning laboratory that will provide transformational opportunities for our students. The Aplin Center will positively impact Aggies for generations to come.”

Buc-ee’s founder, in turn, noted that Banks’ vision of a “world-class hospitality entrepreneurship program” is “just what Texas A&M needs and I’m proud to have an opportunity to be involved.”

Two years after graduation, Aplin opened his first Buc-ee’s in 1982 in Lake Jackson. His beaver empire has since expanded into five other states, with development underway in another five. Aplin’s brand hallmarks include pristine restrooms, endless fuel pumps, a vast selection of food and consumer items.

Besides its reputation as a cult and customer favorite, Buc-ee’s offers health insurance to employees and pays more than twice the amount of minimum wage. Earlier this year, the convenience store-rest stop hybrid received nationwide attention on CBS Sunday Morning. July 28 marks Buc-ee’s 40th anniversary.

“When Beaver Aplin does something, it’s never halfway,” said A&M System chancellor John Sharp in a statement. “The love he has and shows for Texas A&M and Aggies is inspirational and appreciated. This is an awesome gift and will position Texas A&M to become the top hospitality program in the nation.”

An Aggie through and through, Aplin, who serves on myriad boards and is also chairman of Texas Parks and Wildlife, once preached the College Station gospel during a lecture in 2012, telling the class, “I have to remember — I’ve gotta stay Beaver. I’ve gotta stay Buc-ee’s. I’ve gotta stay Aggie and I’ve gotta stay who I am.”

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”